Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women (people who were assigned female sex at birth) who have been diagnosed with coronary heart disease — for example, those who have had heart bypass surgery, a stent procedure, a heart attack, or certain types of reduced blood flow to the heart — at least 4 weeks after their procedure or cardiac event.
- People who are able to complete a supervised exercise test that measures heart and lung performance (called a CPET), which is used to measure fitness and plan a safe exercise program.
- People who can read and understand English or French.
Who may not be able to join:
- People who are already doing regular, structured exercise more than twice a week (such as a planned fitness routine aimed at maintaining or improving fitness).
- People who have severe heart failure symptoms (classified as NYHA class III or IV), unstable chest pain (unstable angina), or a confirmed diagnosis of chronic obstructive pulmonary disease, severe narrowing of the mitral or aortic heart valves, or a specific thickening of the heart muscle that blocks blood flow (hypertrophic obstructive cardiomyopathy).
- People who have an uncontrolled irregular heartbeat (arrhythmia), as this could affect how exercise intensity is safely monitored and planned.
- People who are not able to provide written consent to participate.
- People who are not willing or not able to come back for follow-up visits at 12 weeks and 26 weeks after joining.
- People who are not willing to be randomly assigned to one of the two exercise programs being studied.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer Reed, PhD, Ottawa Heart Institute Research Corporation
Phone: 613-696-7392
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Exercise capacity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.